BfArM — authorised 11 January 2019
- Marketing authorisation holder: AETERNA ZENTARIS GMBH
- Status: approved
BfArM authorised Macrilen on 11 January 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM authorised it on 11 January 2019.
AETERNA ZENTARIS GMBH holds the German marketing authorisation.